Click image to enlarge
The R-PLEX platform offers both antibody sets and assays for a wide menu of biomarkers. The R-PLEX Human ACE2 Assay has the essential components to build an assay that measure ACE2 in a single analyte format. For information on multiplexing ACE2 with other analytes, please see the
R-PLEX Assay Designer or the
R-PLEX Human ACE2 Antibody Set.
The Product Insert for R-PLEX Assays provides detailed instructions for building a singleplex assay. The datasheet for ACE2 provides information on the components (including calibrator stock concentration), recommended sample types and dilution factors, and representative data for analytical performance. These items and other helpful documents can be found in the "Documentation" tab below.
Related Key TermsAngiotensin converting enzyme 2, metalloprotease MPROT15
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
|
Application(s)
|
|
Cardiovascular
|
|
|
Analyte(s)
|
|
ACE2
|
|
|
Species
|
|
Human
|
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
SECTOR Imager 6000
,
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120
|
|
|
Plate Type
|
|
96-well
|
|
|
LLOD (Sensitivity)
|
|
30.6 pg/mL
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Gene ID(s)
|
|
59272
|
|
|
UniProt ID(s)
|
|
Q9BYF1
|
|
|
Schedule B Code
|
|
3002.15.0100
|
|
|
Product Description
|
Storage
|
Quantity per Kit
|
|
Human ACE2 Antibody Set
|
2-8 °C
|
1 each
(5 plate size)
|
|
|
|
Human ACE2 Calibrator
|
≤-70 °C
|
5 vial
(1 vial)
|
|
|
|
|
2-8 °C
|
5 each
(1 plate)
|
|
|
|
|
2-8 °C
|
1 bottle
(50 mL)
|
|
|
|
|
≤-10 °C
|
2 bottle
(50 mL)
|
|
|
|
|
RT
|
1 bottle
(90 mL)
|
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
Handouts
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
|
|
|
|
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
|
|
|
|
SARS-CoV-2 -specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
|
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters